Monopar Therapeutics' Series A Round

Monopar Therapeutics raised a round of funding on November 14, 2017.

Monopar Therapeutics is an emerging biopharmaceutical company focused on developing innovative drug combinations to improve clinical outcomes in advanced cancer. Monopar currently has two compounds in…

Articles about Monopar Therapeutics' Series A Round: